Casto-Boggess L, Holland L
Anal Chim Acta. 2024; 1296:342268.
PMID: 38401944
PMC: 10911858.
DOI: 10.1016/j.aca.2024.342268.
Haslund-Gourley B, Aziz P, Heithoff D, Restagno D, Fried J, Ilse M
PNAS Nexus. 2022; 1(3):pgac113.
PMID: 35967980
PMC: 9364217.
DOI: 10.1093/pnasnexus/pgac113.
Tomin A, Dumych T, Tolstyak Y, Kril I, Mahorivska I, Bila E
Clin Exp Immunol. 2014; 179(1):17-23.
PMID: 24580640
PMC: 4260892.
DOI: 10.1111/cei.12312.
Zamora C, dAlarcao M, Kumar K
Bioorg Med Chem Lett. 2013; 23(11):3406-10.
PMID: 23639536
PMC: 4695216.
DOI: 10.1016/j.bmcl.2013.03.076.
Drake C, Miller D, Jones E
Curr Org Synth. 2013; 8(4):498-520.
PMID: 23519774
PMC: 3601828.
DOI: 10.2174/157017911796117232.
Macrophages discriminate glycosylation patterns of apoptotic cell-derived microparticles.
Bilyy R, Shkandina T, Tomin A, Munoz L, Franz S, Antonyuk V
J Biol Chem. 2011; 287(1):496-503.
PMID: 22074924
PMC: 3249103.
DOI: 10.1074/jbc.M111.273144.
Anti-influenza virus agents: synthesis and mode of action.
Lagoja I, De Clercq E
Med Res Rev. 2006; 28(1):1-38.
PMID: 17160999
PMC: 7168508.
DOI: 10.1002/med.20096.
Influenza virus neuraminidase contributes to secondary bacterial pneumonia.
Peltola V, Murti K, McCullers J
J Infect Dis. 2005; 192(2):249-57.
PMID: 15962219
PMC: 2715995.
DOI: 10.1086/430954.
Human parainfluenza virus type 3 HN-receptor interaction: effect of 4-guanidino-Neu5Ac2en on a neuraminidase-deficient variant.
Porotto M, Greengard O, Poltoratskaia N, Horga M, Moscona A
J Virol. 2001; 75(16):7481-8.
PMID: 11462020
PMC: 114983.
DOI: 10.1128/JVI.75.16.7481-7488.2001.
A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity.
Murrell M, Porotto M, Greengard O, Poltoratskaia N, Moscona A
J Virol. 2001; 75(14):6310-20.
PMID: 11413297
PMC: 114353.
DOI: 10.1128/JVI.75.14.6310-6320.2001.
Mechanism of interference mediated by human parainfluenza virus type 3 infection.
Horga M, Gusella G, Greengard O, Poltoratskaia N, Porotto M, Moscona A
J Virol. 2000; 74(24):11792-9.
PMID: 11090179
PMC: 112462.
DOI: 10.1128/jvi.74.24.11792-11799.2000.
The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA.
Greengard O, Poltoratskaia N, Leikina E, Zimmerberg J, Moscona A
J Virol. 2000; 74(23):11108-14.
PMID: 11070006
PMC: 113191.
DOI: 10.1128/jvi.74.23.11108-11114.2000.
Detecting and minimizing glycosidase activities that can hydrolyze sugars from cell culture-produced glycoproteins.
Gramer M
Mol Biotechnol. 2000; 15(1):69-75.
PMID: 10911624
DOI: 10.1385/MB:15:1:69.
Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics.
Wagner R, Wolff T, Herwig A, Pleschka S, Klenk H
J Virol. 2000; 74(14):6316-23.
PMID: 10864641
PMC: 112137.
DOI: 10.1128/jvi.74.14.6316-6323.2000.
The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties.
Matrosovich M, Zhou N, Kawaoka Y, Webster R
J Virol. 1999; 73(2):1146-55.
PMID: 9882316
PMC: 103935.
DOI: 10.1128/JVI.73.2.1146-1155.1999.
Immunogenicity and protective efficacy in mice of influenza B virus vaccines grown in mammalian cells or embryonated chicken eggs.
Alymova I, Kodihalli S, Govorkova E, Fanget B, Gerdil C, Webster R
J Virol. 1998; 72(5):4472-7.
PMID: 9557744
PMC: 109684.
DOI: 10.1128/JVI.72.5.4472-4477.1998.
Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en.
Gubareva L, Robinson M, Bethell R, Webster R
J Virol. 1997; 71(5):3385-90.
PMID: 9094607
PMC: 191482.
DOI: 10.1128/JVI.71.5.3385-3390.1997.
The cytoplasmic tail of influenza A virus neuraminidase (NA) affects NA incorporation into virions, virion morphology, and virulence in mice but is not essential for virus replication.
Mitnaul L, Castrucci M, Murti K, Kawaoka Y
J Virol. 1996; 70(2):873-9.
PMID: 8551626
PMC: 189890.
DOI: 10.1128/JVI.70.2.873-879.1996.
Sialidosis type I: first report in the Czech population of two siblings with cherry-red spot myoclonus syndrome but without sialyloligosacchariduria.
Ledvinova J, Poupetova H, Elleder M, Tichy J, Penickova V, Harzer K
J Inherit Metab Dis. 1994; 17(1):118-9.
PMID: 8051919
DOI: 10.1007/BF00735411.
Fusion between Newcastle disease virus and erythrocyte ghosts using octadecyl Rhodamine B fluorescence assay produces dequenching curves that fit the sum of two exponentials.
Cobaleda C, Garcia-Sastre A, Villar E
Biochem J. 1994; 300 ( Pt 2):347-54.
PMID: 8002938
PMC: 1138168.
DOI: 10.1042/bj3000347.